Oncology estimand working group

Published

December 18, 2024

Purpose

Find on this webpage information on the working group on estimands in oncology.

Status

The working group has been very successful in supporting implementation of the ICH E9(R1) estimands addendum in routine drug development, see talks and publications.

The working group officially ended its activities at the end of 2024.

Some of the taskforces will continue their work under other EFSPI / PSI / ASA working groups and may take new members. Please directly reach out to them as indicated here.

This homepage will remain online as a repository of the WG’s work for the foreseeable future.

Membership in professional organizations

In November 2018, the working group was established by EFSPI as European special interest group “Estimands in oncology”, sponsored by PSI and EFSPI and in June 2019 the ASA biopharmaceutical section has granted the official status as ASA scientific working group.

Links to this page

Link to this page: http://www.oncoestimand.org.
Github repo: https://github.com/oncoestimand